1. Home
  2. DNN vs WVE Comparison

DNN vs WVE Comparison

Compare DNN & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denison Mines Corp (Canada)

DNN

Denison Mines Corp (Canada)

HOLD

Current Price

$4.14

Market Cap

3.3B

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$12.95

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNN
WVE
Founded
1954
2012
Country
Canada
Singapore
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.0B
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
DNN
WVE
Price
$4.14
$12.95
Analyst Decision
Strong Buy
Analyst Count
0
16
Target Price
N/A
$29.94
AVG Volume (30 Days)
54.3M
4.7M
Earning Date
03-12-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,493,456.00
$109,230,000.00
Revenue This Year
$197.29
N/A
Revenue Next Year
$55.12
$16.20
P/E Ratio
N/A
N/A
Revenue Growth
23.35
103.75
52 Week Low
$1.08
$5.28
52 Week High
$4.43
$21.73

Technical Indicators

Market Signals
Indicator
DNN
WVE
Relative Strength Index (RSI) 73.15 41.30
Support Level $3.66 $12.55
Resistance Level $4.43 $13.77
Average True Range (ATR) 0.22 0.81
MACD 0.05 -0.26
Stochastic Oscillator 78.26 11.70

Price Performance

Historical Comparison
DNN
WVE

About DNN Denison Mines Corp (Canada)

Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: